Manuel Hidalgo Medina

Manuel Hidalgo Medina
Known for
Scientific career
Fieldsoncology
InstitutionsBeth Israel Deaconess Medical Center

Manuel Hidalgo Medina is an oncologist. He is director of the Leon V. and Marilyn L. Rosenberg Clinical Cancer Center at Beth Israel Deaconess Medical Center in Boston, Massachusetts, in the United States; he also heads its hematology/oncology division.[1] He specializes in pancreatic cancer. His research has included development of anti-cancer drugs such as erlotinib, nab-paclitaxel and temsirolimus, and the development of patient-derived tumor xenograft models.[1]

Recognition

Hidalgo received a research grant from the American Society of Clinical Oncology Conquer Cancer Foundation in 2001.[2]

References

  1. ^ a b Manuel Hidalgo Medina, MD, PhD. Boston. Archived 1 August 2019.
  2. ^ "Grant and Award Recipients".
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.